Epstein Secrets

Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: MD HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS . STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YE

Hemoglobin 15.6 13.6.17.6 g/dL Hernatocrit 47.8 40.2-51.4 ok MCV 88.2 82.5-96.5 MCH 28.8 27.1-34.9 Pg MCHC L 32.6 33.0-37.0 g/dL RDW-CV 12.8 12.0-14.0 Platelet 338 130-374 K/uL FLAG LEGEND La-Low LI=Low Critical H=High HI=-HIgh Critical A=Abnormal Al =Abnormal Critical Page

uma Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

emoglobin 15.6 13.6-17.6 g/dL Hematocrit 47.8 40.2-51.4 ok MCV 88.2 82.5-96.5 IL MCH 28.8 27.1-34.9 PO MCHC L 32.6 33.0-37.0 g/dL RDW-CV 12.8 12.0-14.0 ok Platelet 338 130-374 KJul FLAG LEGEND La-Low LI=Low Critical H=High HI=HIgh Critical A=Abnormal Al =Abnormal Critical Page

ervices. SUBJECTIVE: COMPLAINT 1 Provider: Beaudouin, Robert MD Chief Complaint: ENDO/LIPID Subjective: 66 YR OL HITE MALE WITH HX OF HYPERT CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS 800 , . STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE MEDS • EIR GI SIDE EFFECTS. HX OF

78 Hemoglobin 4.5.6 13.6-17.6 g/dL Hematocrit 47.8 40.2-51.4 MCV 88.2 82.5.96.5 fL MCH 28.8 27.1-34.9 P9 MCHC 32.6 33.0-37.0 g/dL RDW-CV 12.8 12.0-14.0 Platelet 338 130-374 K/uL FLAG LEGEND L=Low LI.=Low Critical H=High H!=High Critical A=Abnormal A! =Abnormal Critical Page 1

Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: MD HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12

Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: MD HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12

uma Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12

uma Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12